Blockchain Registration Transaction Record
ANDARIX Pharmaceuticals CEO to Lead Session at Targeted Therapy Conference in Boston
ANDARIX Pharmaceuticals CEO to chair session at targeted therapy conference in Boston, showcasing advancements in personalized cancer therapies and optimal targeting strategies. Industry experts and patient groups convene to discuss latest developments.

This news highlights the innovative work being done by ANDARIX Pharmaceuticals in the field of targeted peptide therapy for rare cancers, showcasing their commitment to advancing personalized treatment options. The conference provides a platform for industry leaders to collaborate and share insights, ultimately driving progress in the fight against cancer.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x6fb09765db4d57c0e7c106e44c1fbe4235bb2e2aa7fc61a96a755d905cd6e256 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | kiwi3A1l-5c312bf1d52039d9f095ae738cf6acd8 |